Neostigmine Bromide/Anisodamine Hydrobromide

溴新斯的明/氢溴酸山莨菪碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNeostigmine Bromide/Anisodamine Hydrobromide
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAcetylcholinesterase inhibitorsMuscle relaxation antagonistsAdrenergic receptor alpha-1 antagonists +[4] 
TargetsAcetylcholinesteraseMuscarinic acetylcholine receptorAdrenergic receptors alpha-1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Neostigmine BromideAnisodamine Hydrobromide
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesSecond Military Medical University Of Chinese People'S Liberation ArmyGore Pharmaceutical Technology (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGore Pharmaceutical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A